The Effects of Serelaxin in Coronary Artery Disease

• Research type

  Research Study

• Full title

  A multicenter, double blind, randomized, parallel group, placebo-controlled study to evaluate the effects of intravenous serelaxin infusion on micro- and macro-vascular function in subjects with coronary artery disease.

• IRAS ID

  114911

• Contact name

  Colin Berry

• Contact email

  Colin.Berry@glasgow.ac.uk

• Sponsor organisation

  Novartis Pharma Service AG

• Eudract number

  2012-001945-42

• REC name

  East of Scotland Research Ethics Service REC 2

• REC reference

  13/ES/0088

• Date of REC Opinion

  19 Sep 2013

• REC opinion

  Further Information Favourable Opinion